Welcome to the Molecular Cancer Imaging Facility (MCIF)
Advancing therapeutic and diagnostic research through radiotracer development

MCIF helps investigators quickly move discovery-stage concepts to in-vivo models, generating data to support grant applications, publications, and drug development efforts.  Dana-Farber Cancer Institute has partnered with the Centre for Probe Development and Commercialization based out of Ontario Canada to create novel molecular probes for imaging in cancer research, drug development and patient care.